OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging approaches to CDK inhibitor development, a structural perspective
Ian Hope, Jane Endicott, Jessica E. Watt
RSC Chemical Biology (2022) Vol. 4, Iss. 2, pp. 146-164
Open Access | Times Cited: 9
Ian Hope, Jane Endicott, Jessica E. Watt
RSC Chemical Biology (2022) Vol. 4, Iss. 2, pp. 146-164
Open Access | Times Cited: 9
Showing 9 citing articles:
Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation – A systematic computational approach to discover novel cancer therapeutics
Bharath Kumar Chagaleti, Shantha Kumar B., Anjana G.V., et al.
Computational Biology and Chemistry (2024) Vol. 112, pp. 108134-108134
Closed Access | Times Cited: 21
Bharath Kumar Chagaleti, Shantha Kumar B., Anjana G.V., et al.
Computational Biology and Chemistry (2024) Vol. 112, pp. 108134-108134
Closed Access | Times Cited: 21
Slower CDK4 and faster CDK2 activation in the cell cycle
Wengang Zhang, Yonglan Liu, Hyunbum Jang, et al.
Structure (2024) Vol. 32, Iss. 8, pp. 1269-1280.e2
Closed Access | Times Cited: 9
Wengang Zhang, Yonglan Liu, Hyunbum Jang, et al.
Structure (2024) Vol. 32, Iss. 8, pp. 1269-1280.e2
Closed Access | Times Cited: 9
Assessment of iridoids and their similar structures as antineoplastic drugs by in silico approach
Prabhat Neupane, Jhashanath Adhikari Subin, Rameshwar Adhikari
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-16
Closed Access | Times Cited: 7
Prabhat Neupane, Jhashanath Adhikari Subin, Rameshwar Adhikari
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-16
Closed Access | Times Cited: 7
Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception
Jeanine Giarolla, Kelsey Holdaway, Maryam Nazari, et al.
Future Medicinal Chemistry (2025), pp. 1-21
Closed Access
Jeanine Giarolla, Kelsey Holdaway, Maryam Nazari, et al.
Future Medicinal Chemistry (2025), pp. 1-21
Closed Access
Crystallographic fragment screening of CDK2-cyclin A: FragLites map sites of protein-protein interaction
Ian Hope, Martin E. M. Noble, Michael J. Waring, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Ian Hope, Martin E. M. Noble, Michael J. Waring, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Cell cycle progression mechanisms: slower cyclin-D/CDK4 activation and faster cyclin-E/CDK2
Wengang Zhang, Yonglan Liu, Hyunbum Jang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Wengang Zhang, Yonglan Liu, Hyunbum Jang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Identification of abemaciclib derivatives targeting cyclin-dependent kinase 4 and 6 using molecular dynamics, binding free energy calculation, synthesis, and pharmacological evaluation
Yanting Zhou, Xiandeng Li, Peifang Luo, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Yanting Zhou, Xiandeng Li, Peifang Luo, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Molecular modeling studies of Pyrazolopyrimidine Derivatives as potent Cyclin Dependent Kinase-2 inhibitors
Bharath Kumar Chagaleti, Kathiravan Muthu K
Research Square (Research Square) (2024)
Open Access
Bharath Kumar Chagaleti, Kathiravan Muthu K
Research Square (Research Square) (2024)
Open Access
Potential Target of CDK6 Signaling Pathway for Cancer Treatment
Rajesh Basnet, Obed Boadi Amissah, Buddha Bahadur Basnet, et al.
Current Drug Targets (2024) Vol. 25, Iss. 11, pp. 724-739
Closed Access
Rajesh Basnet, Obed Boadi Amissah, Buddha Bahadur Basnet, et al.
Current Drug Targets (2024) Vol. 25, Iss. 11, pp. 724-739
Closed Access
